Bio-Rad launches ddSEQ™ Single-Cell 3' RNA-Seq Kit for Single-Cell Gene Expression

ddSEQ™ Single-Cell 3' RNA-Seq Kit and Omnition v1.1 Analysis Software Enable High-Quality and Affordable Single-Cell Transcription and Gene Expression to Support Molecular Biology, Oncology, and Drug Discovery Research

Uptake of advanced therapies in psoriasis and psoriatic arthritis

he uptake of innovative advanced treatments in immunology is highly dependent on the indication, with new innovative treatments gaining market share quickly in psoriasis, while older entrenched products still hold considerable market share in psoriatic arthritis.

As Cambridge Wide Open Day buzzes in 2024, get set for Cambridge Wide Open Week in 2025!

The 2nd annual Cambridge Wide Open Day (CWOD) event had Cambridge buzzing last week with curious residents as well as people attending from as far afield as Birmingham and Nottingham, and even Switzerland and the US!

Relate Cambridgeshire joins Salus Wellness

Relate Cambridgeshire offers counselling across Cambridgeshire and specialises in:

Sepsis patients could get the right treatment faster, based on their genes

Sepsis patients could be treated based on their immune system’s response to infection, not their symptoms.

Exploring the complexities of Pulmonary Hypertension

Pulmonary hypertension (PH) is a serious condition characterised by elevated blood pressure within the pulmonary arteries. The pulmonary arteries are responsible for carrying blood from the right-hand side of the heart to the lungs.

Successful trial for new colorectal cancer treatment

Study indicates that immunotherapy could tackle most common form of bowel tumour.

Accelerating drug discovery with the CCDC, AWS, and Intel: Curated Data Set of Protein Structures from the Protein Data Bank with Predicted Hydrogen Positions available

Cambridge, UK – Thanks to the combined computing power of Amazon Web Services (AWS) and Intel, the CCDC announces that a potentially significant advancement in drug discovery has been achieved.

Milner Therapeutics Institute Director Professor Tony Kouzarides awarded a knighthood in King's Birthday Honours List

Professor Tony Kouzarides, Director of the Milner Therapeutics Institute, has been awarded a knighthood for services to healthcare innovation and delivery.

Gyros Protein Technologies introduces Gyrolab Generic Anti-AAV Kit to support gene therapy development

Ready-to-use kit enables detection of binding antibodies against AAV vectors without the need for serotype-specific assays

Animating the science of a firearm - WaveFX

WaveFX writes...our talented CG artists can bring any process to life, for example this STEM based client wanted to show the firing process of a firearm as part of a series of educational videos.

Price Bailey encourages Cambridge based healthcare businesses looking to sell, to act now

With the general election announced for July,  Price Bailey is urging healthcare businesses to sell up now to avoid potential post-election tax hikes. 

Enterprise Therapeutics appoints Dr Renu Gupta as Chief Medical Officer and Dr Janet Hammond as Non-Executive Director

Brighton, UK: Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering from respiratory

Sphere Fluidics awarded Gold accreditation by Investors in People

Internationally-recognized ‘We invest in people’ award is certified recognition of the Company’s care and commitment to its employees globally

Why digital matters for neurodegeneration treatments

Author(s): Molly Andrews, UK Dementia Research Institute; Priya Kalia, SciTribe; Miranda Weston-Smith, BioBeat.

Surgeon’s battle to put a smile on Brenda’s face

Imagine not being able to smile? That is the predicament facing patient Brenda when she appears in the sixth episode of The Face Doctors, at 9pm on Really on Wednesday (19 June), and available to stream via discovery+.

Business leader and technologist David Parker joins Amadeus as Venture Partner

Cambridge, UK – Amadeus Capital Partners, the global technology investor, is delighted to welcome Dr. David Parker as a part time Venture Partner to its early stage, deep tech investing team.

Lucida Medical Ltd announces a distribution agreement with Sectra to offer Pi AI technology to help diagnose prostate cancer

Lucida Medical announces that it has signed a distribution agreement with international medical imaging IT and cybersecurity company Sectra.

Enterprise Therapeutics publishes preclinical profile of ETD001, a novel inhaled ENaC blocker

Cutting-edge virtual ward wins digital accolade

An initiative by Addenbrooke’s which has enabled more than 1,800 patients to be treated in the comfort of their own homes won a national award on Thursday, 6 June.

Newcells Biotech strengthens executive and US team with key appointments

Cambridge-based Cofinitive Communications recognised amongst international PR and Communications industry elite

Cambridge-based PR & Comms agency, Cofinitive Communications has been listed in PR Week’s Top 150 PR agency rankings for a third consecutive year.

I do not live with diabetes – should I be monitoring my glucose with CGM?

Nowadays, CGMs are being promoted by various biotech companies and social media influencers as tools for understanding and improving health. Unfortunately, I can see a rise in poorly evidenced health messages. In addition, there are many misleading ads risking people’s health.

The inaugural Cambridge Independent Business Awards are now open for entry

Cambridge Independent are pleased to announce the launch of the inaugural Cambridge Independent Business Awards. A celebration of all business sectors in the Cambridge region, the awards will culminate in a gala event in the magnificent Great Hall at King’s College on 26 September.

Experts launch team effort to help patient Alex

The fifth episode of The Face Doctors on Really, shown at 9pm on Wednesday (12 June) tells the story of a patient who became a prisoner in his own home after his entire nose was lost to cancer.